PPAR-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow

Cell Biol Int. 2013 May;37(5):430-5. doi: 10.1002/cbin.10046. Epub 2013 Mar 18.

Abstract

Selective peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist affects the functions of endothelial progenitor cells (EPCs). This study explores the effect of selective PPAR-γ agonist, pioglitazone, on EPC apoptosis. The cells were cultured and identified via the double staining method in a medium containing different concentrations of pioglitazone. EPC apoptosis was detected by flow cytometry. On Day 7, EPCs engulfed DiL-ac-LDL and FITC-UEA-1, and showed yellow fluorescence in a laser-scanning confocal microscope. EPC apoptosis inhibition was maximal at 50 µmol/L. The ability of pioglitazone to prevent EPC apoptosis may be mediated by the PI3K/Akt signal pathway. The use of thiazolidine two ketone (TZD) to reduce EPC apoptosis may have some potential in treating vascular diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Bone Marrow Cells / cytology*
  • Cells, Cultured
  • Fluorescent Dyes / chemistry
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology*
  • Male
  • PPAR gamma / agonists*
  • PPAR gamma / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Pioglitazone
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Stem Cells / cytology
  • Stem Cells / drug effects*
  • Stem Cells / metabolism
  • Thiazolidinediones / chemistry
  • Thiazolidinediones / pharmacology*

Substances

  • Fluorescent Dyes
  • Hypoglycemic Agents
  • PPAR gamma
  • Thiazolidinediones
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Pioglitazone